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Background: Carbapenemase-producing Klebsiella pneumoniae
(CPK) isolates have emerged as major causes of health care-
associated infections worldwide. The present study was conducted
to investigate the most prevalent carbapenemase genes; blaOXA-
48, blaVIM, blaIMP, blaNDM and blaKPC in CPK isolates from blood
culture of hospitalized patients at Istanbul University Cerrahpasa
Medical School hospital.
Methods&Materials: Between January2012andOctober 2015,
a total of 100 CPK isolates were isolated from blood culture sam-
ples of hospitalized patientswith bacteremia in intensive care units
and in various departments of our hospital. Blood cultures were
analyzed with the BACTEC system (Becton Dickinson,USA). The
identiﬁcation and antimicrobial resistance of CPK isolates were
determined by Phoenix automated system (BDDiagnostic Systems,
Sparks,MD). Thedetection of carbapenemase geneswasperformed
by real-time PCRusingMDRKPC/OXAReal-TMandMDRMBL (VIM,
IMP, NDM) Real-TM PCR kit (Sacace Biotechnologie, Italie).
Results: ESBL rate was 87% in CPK isolates. All isolates
were phenotypically positive for carbapenemase activity. The
isolates were highly resistant to cefuroxime (96%), and amoxi-
cillin/clavulanic acid (91%), ceftriaxone, cefotaxime, ceftazidime
(87%), piperacillin/tazobactam (86%), cefepime (82%), ciproﬂoxacin
(76%) and gentamicin (65%). Amikacin resistance ratewas 18%. Col-
istin and tigecycline resistance rates were 1%. The carbapenemase
gene blaOXA-48 was detected in 43% of isolates and blaVIM in 5%.
One isolateharboreda combinationofblaOXA-48andblaVIM.None
of the isolates harbored blaNDM, blaKPC or blaIMP.
Conclusion: The carbapenemase genes blaOXA-48 with blaVIM
was isolated in one of our isolates. Signiﬁcant effort must be made
to prevent the spread of CPK and continuous monitoring of drug
resistance is necessary in our clinical settings.
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Detection of IMP, VIM and NDM
metallo-betalactamase carbapenemase genes in
carbapenem resistant pseudomonas strains
from bloodstream infections in Istanbul, Turkey
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Ozturk
Istanbul University, Cerrahpasa Faculty of Medicine,
Istanbul, Turkey
Background: Carbapenem–resistant Pseudomonas aeruginosa
causing various life-threatening infections is an important prob-
lemworldwide. Carbapenemase genes are oneof themost common
mechanisms reported in carbapenem-resistantP. aeruginosa. In this
study, we aimed to determine the presence of IMP, VIM and NDM
metallo-betalactamase (MBL) carbapenemase genes.
Methods & Materials: Between 2011 and 2015, a total of 48
carbapenem–resistant/intermediatePseudomonas strainswere iso-
lated from blood samples of patients with bacteremia who were
hospitalized in intensive care units and in various departments
at Istanbul University Cerrahpasa Medical Faculty hospital. Blood
cultures were analyzed with the BACTEC system (Becton Dickin-
son, USA). The identiﬁcation and antimicrobial resistance of the
strains were determined by Phoenix automated system (BD Diag-
nostic Systems, Sparks, MD). Phenotypic MBL E-test was used to
investigate the presence of MBL enzymes. All study strains were
screened by multiplex PCR for the presence of MBL genes.
Results: The species distribution was as follows: P. aeruginosa
42 (87.5%), P. putida 5 (10,4%) and P. ﬂuorescens 1(2.1%).
Thirty six (76%) of isolates were carbapenem-resistant (MIC 8-
≥32g/mL), 12 (25%) intermediate resistant (MIC 6g/mL).MIC50
and MIC90 were respectively 32g/mL and 32g/mL to both
imipenem and meropenem. Resistance rates of the isolates to the
antibacterial agents, respectively, were as follows: sefepim and
ticarcillin 56%, levoﬂoxacin 52%, ciproﬂoxacin 50%, ceftazidime
48%, piperacillin/tazobactam 46%, tobramycin and netilmycin 44%,
gentamicin and aztreonam 37.5%, and amikacin 29%. None of the
isolates were resistant to colistin. MBL screening with EDTA was
positive in 6.3% (n=3). In these three isolates with MBL positive,
VIM type MBL gene was detected in two P. aeruginosa and one
P. putida. NDM and IPM-type MBL genes were not in any of the
isolates.
Conclusion: In our study, VIM type MBL gene was ﬁrst shown
in Pseudomonas strains at our hospital. Therefore, identiﬁcation of
carbapenemase genes restricting treatment options is important to
rational antibiotic use and also to implement infection prevention
measures to reduce their spreading.
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